Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib maintenance after postoperative chemoradiotherapy for squamous cell carcinoma of the head and neck
2010-023265-22Phase 3Completed
- Sponsor
- Centre Léon Bérard
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in head and neck squamous cell carcinoma (HNSCC) comparing Afatinib maintenance with Placebo maintenance (2 arms). Primary endpoint: Disease-free survival. Started Jul 2011; status: completed.
02
Drugs
afatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2010-023265-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023265-22.